Skip to main content
SpringerLink
Log in

Plasma tissue factor pathway inhibitor levels in patients with acute pancreatitis

  • Original Article—Liver, Pancreas, and Biliary Tract
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Background

In acute pancreatitis (AP), disorders of the coagulation-fibrinolysis system are closely related to the severity of the AP and to organ dysfunctions. We previously reported that plasma tissue factor (TF) levels were elevated in patients with AP, particularly in cases of alcoholic AP with pancreatic necrosis. Tissue factor pathway inhibitor (TFPI) is a key regulator of the extrinsic coagulation pathway, but plasma TFPI levels in AP have not yet been determined.

Methods

Plasma TFPI concentrations were measured by enzyme-linked immunosorbent assay in 44 patients with AP on admission. The relationships between AP severity, pancreatic necrosis, organ dysfunction, infection, and prognosis were analyzed.

Results

Plasma TFPI levels were increased in AP patients compared with healthy volunteers. Plasma TFPI levels in severe AP were greater than those in mild AP. Plasma TFPI levels significantly correlated with Ranson score, APACHE II score, and Japanese severity score. Plasma TFPI levels in patients with pancreatic necrosis were greater than those in patients without pancreatic necrosis. Plasma TFPI levels in patients with organ dysfunction were greater than those in patients without organ dysfunction. In patients with pancreatic necrosis, the TF/TFPI ratios in non-survivors were lower than those in survivors. Moreover, the mortality rates in patients with TF/TFPI ratios ≥ 2.0 were lower than those in patients with TF/TFPI ratios < 2.0.

Conclusions

Plasma TFPI levels were significantly increased in patients with AP, and the elevation was markedly related to the severity, pancreatic necrosis and organ dysfunctions. The imbalance of TF and TFPI may influence the disease state and thereby the prognosis in AP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Lasson A, Ohlsson K. Disseminated intravascular coagulation and antiprotease activity in acute human pancreatitis. Scand J Gastroenterol Suppl. 1996;126:35–9.

    Google Scholar 

  2. Tenner S, Sica G, Hughes M, Noordhoek E, Feng S, Zinner M, et al. Relationship of necrosis to organ failure in severe acute pancreatitis. Gastroenterology. 1997;113:899–903.

    Article  PubMed  CAS  Google Scholar 

  3. Foitzik T, Eibl G, Hotz B, Hotz H, Kahrau S, Kasten C, et al. Persistent multiple organ microcirculatory disorders in severe acute pancreatitis: experimental findings and clinical implications. Dig Dis Sci. 2002;47:130–8.

    Article  PubMed  CAS  Google Scholar 

  4. Agarwal N, Pitchumoni CS. Acute pancreatitis: a multisystem disease. Gastroenterologist. 1993;1:115–28.

    PubMed  CAS  Google Scholar 

  5. Spicer EK, Horton R, Bloem L, Bach R, Williams KR, Guha A, et al. Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDNA. Proc Natl Acad Sci USA. 1987;84:5148–52.

    Article  PubMed  CAS  Google Scholar 

  6. ten Cate H, Bauer KA, Levi M, Edgington TS, Sublett RD, Barzegar S, et al. The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor. J Clin Invest. 1993;92:1207–12.

    Article  PubMed  Google Scholar 

  7. Ruf W, Edgington TS. Structural biology of tissue factor, the initiator of thrombogenesis in vivo. Faseb J. 1994;8:385–90.

    PubMed  CAS  Google Scholar 

  8. Shimura M, Wada H, Wakita Y, Nakase T, Hiyoyama K, Nagaya S, et al. Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation. Am J Hematol. 1996;52:165–70.

    Article  PubMed  CAS  Google Scholar 

  9. Gando S, Nanzaki S, Sasaki S, Aoi K, Kemmotsu O. Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock. Crit Care Med. 1998;26:2005–9.

    Article  PubMed  CAS  Google Scholar 

  10. Leatham EW, Bath PM, Tooze JA, Camm AJ. Increased monocyte tissue factor expression in coronary disease. Br Heart J. 1995;73:10–3.

    Article  PubMed  CAS  Google Scholar 

  11. Sawa H, Ueda T, Takeyama Y, Yasuda T, Matsumura N, Nakajima T, et al. Elevation of plasma tissue factor levels in patients with severe acute pancreatitis. J Gastroenterol. 2006;41:575–81.

    Article  PubMed  CAS  Google Scholar 

  12. Broze GJ Jr, Warren LA, Novotny WF, Higuchi DA, Girard JJ, Miletich JP. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action. Blood. 1988;71:335–43.

    PubMed  CAS  Google Scholar 

  13. Girard TJ, Warren LA, Novotny WF, Likert KM, Brown SG, Miletich JP, et al. Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor. Nature. 1989;338:518–20.

    Article  PubMed  CAS  Google Scholar 

  14. Novotny WF, Girard TJ, Miletich JP, Broze GJ Jr. Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor. Blood. 1988;72:2020–5.

    PubMed  CAS  Google Scholar 

  15. Yamamuro M, Wada H, Kumeda K, Inoue A, Tsuji I, Nakasaki T, et al. Changes in plasma tissue factor pathway inhibitor levels during the clinical course of disseminated intravascular coagulation. Blood Coagul Fibrinolysis. 1998;9:491–7.

    Article  PubMed  CAS  Google Scholar 

  16. Gando S, Kameue T, Morimoto Y, Matsuda N, Hayakawa M, Kemmotsu O. Tissue factor production not balanced by tissue factor pathway inhibitor in sepsis promotes poor prognosis. Crit Care Med. 2002;30:1729–34.

    Article  PubMed  CAS  Google Scholar 

  17. Kamikura Y, Wada H, Yamada A, Shimura M, Hiyoyama K, Shiku H, et al. Increased tissue factor pathway inhibitor in patients with acute myocardial infarction. Am J Hematol. 1997;55:183–7.

    Article  PubMed  CAS  Google Scholar 

  18. Soejima H, Ogawa H, Yasue H, Kaikita K, Nishiyama K, Misumi K, et al. Heightened tissue factor associated with tissue factor pathway inhibitor and prognosis in patients with unstable angina. Circulation. 1999;99:2908–13.

    PubMed  CAS  Google Scholar 

  19. Golino P, Ravera A, Ragni M, Cirillo P, Piro O, Chiariello M. Involvement of tissue factor pathway inhibitor in the coronary circulation of patients with acute coronary syndromes. Circulation. 2003;108:2864–9.

    Article  PubMed  CAS  Google Scholar 

  20. Abraham E, Reinhart K, Svoboda P, Seibert A, Olthoff D, Dal Nogare A, et al. Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebo-controlled, single-blind, dose escalation study. Crit Care Med. 2001;29:2081–9.

    Article  PubMed  CAS  Google Scholar 

  21. Carraway MS, Welty-Wolf KE, Miller DL, Ortel TL, Idell S, Ghio AJ, et al. Blockade of tissue factor: treatment for organ injury in established sepsis. Am J Respir Crit Care Med. 2003;167:1200–9.

    Article  PubMed  Google Scholar 

  22. LaRosa SP, Opal SM. Tissue factor pathway inhibitor and antithrombin trial results. Crit Care Clin. 2005;21:433–48.

    Article  PubMed  CAS  Google Scholar 

  23. Ogawa M, Hirota M, Hayakawa T, Matsuno S, Watanabe S, Atomi Y, et al. Development and use of a new staging system for severe acute pancreatitis based on a nationwide survey in Japan. Pancreas. 2002;25:325–30.

    Article  PubMed  Google Scholar 

  24. Ueda T, Takeyama Y, Yasuda T, Kamei K, Satoi S, Sawa H, et al. Utility of new Japanese severity score and indication for special therapies in acute pancreatitis. J Gastroenterol 2009; Mar 25 (Epub ahead of print).

  25. Ranson JH, Rifkind KM, Roses DF, Fink SD, Eng K, Spencer FC. Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet. 1974;139:69–81.

    PubMed  CAS  Google Scholar 

  26. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818–29.

    Article  PubMed  CAS  Google Scholar 

  27. Balthazar EJ, Robinson DL, Megibow AJ, Ranson JH. Acute pancreatitis: value of CT in establishing prognosis. Radiology. 1990;174:331–6.

    PubMed  CAS  Google Scholar 

  28. Novotny WF, Palmier M, Wun TC, Broze GJ Jr, Miletich JP. Purification and properties of heparin-releasable lipoprotein-associated coagulation inhibitor. Blood. 1991;78:394–400.

    PubMed  CAS  Google Scholar 

  29. Warn-Cramer BJ, Rao LV, Maki SL, Rapaport SI. Modifications of extrinsic pathway inhibitor (EPI) and factor Xa that affect their ability to interact and to inhibit factor VIIa/tissue factor: evidence for a two-step model of inhibition. Thromb Haemost. 1988;60:453–6.

    PubMed  CAS  Google Scholar 

  30. Novotny WF, Girard TJ, Miletich JP, Broze GJ Jr. Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma. J Biol Chem. 1989;264:18832–7.

    PubMed  CAS  Google Scholar 

  31. Lindahl AK, Jacobsen PB, Sandset PM, Abildgaard U. Tissue factor pathway inhibitor with high anticoagulant activity is increased in post-heparin plasma and in plasma from cancer patients. Blood Coagul Fibrinolysis. 1991;2:713–21.

    Article  PubMed  CAS  Google Scholar 

  32. Nordfang O, Bjorn SE, Valentin S, Nielsen LS, Wildgoose P, Beck TC, et al. The C-terminus of tissue factor pathway inhibitor is essential to its anticoagulant activity. Biochemistry. 1991;30:10371–6.

    Article  PubMed  CAS  Google Scholar 

  33. Hansen JB, Huseby KR, Huseby NE, Ezban M, Nordoy A. Tissue factor pathway inhibitor in complex with low density lipoprotein isolated from human plasma does not possess anticoagulant function in tissue factor-induced coagulation in vitro. Thromb Res. 1997;85:413–25.

    Article  PubMed  CAS  Google Scholar 

  34. Bendz B, Andersen TO, Sandset PM. A new sensitive chromogenic substrate assay of tissue factor pathway inhibitor type 1. Thromb Res. 2000;97:463–72.

    Article  PubMed  CAS  Google Scholar 

  35. Dahm AE, Andersen TO, Rosendaal F, Sandset PM. A novel anticoagulant activity assay of tissue factor pathway inhibitor I (TFPI). 2005;3:651–8.

  36. Novotny WF, Brown SG, Miletich JP, Rader DJ, Broze GJ Jr. Plasma antigen levels of the lipoprotein-associated coagulation inhibitor in patient samples. Blood. 1991;78:387–93.

    PubMed  CAS  Google Scholar 

  37. Broze GJ Jr. Tissue factor pathway inhibitor and the current concept of blood coagulation. Blood Coagul Fibrinolysis. 1995;6:S7–13.

    Article  PubMed  CAS  Google Scholar 

  38. Lupu C, Lupu F, Dennehy U, Kakkar VV, Scully MF. Thrombin induces the redistribution and acute release of tissue factor pathway inhibitor from specific granules within human endothelial cells in culture. Arterioscler Thromb Vasc Biol. 1995;15:2055–62.

    PubMed  CAS  Google Scholar 

  39. Lupu C, Kruithof EK, Kakkar VV, Lupu F. Acute release of tissue factor pathway inhibitor after in vivo thrombin generation in baboons. Thromb Haemost. 1999;82:1652–8.

    PubMed  CAS  Google Scholar 

  40. Drew AF, Davenport P, Apostolopoulos J, Tipping PG. Tissue factor pathway inhibitor expression in atherosclerosis. Lab Invest. 1997;77:291–8.

    PubMed  CAS  Google Scholar 

  41. Tang H, Ivanciu L, Popescu N, Peer G, Hack E, Lupu C, et al. Sepsis-induced coagulation in the baboon lung is associated with decreased tissue factor pathway inhibitor. Am J Pathol. 2007;171:1066–77.

    Article  PubMed  CAS  Google Scholar 

  42. Foitzik T, Eibl G, Hotz HG, Faulhaber J, Kirchengast M, Buhr HJ. Endothelin receptor blockade in severe acute pancreatitis leads to systemic enhancement of microcirculation, stabilization of capillary permeability, and improved survival rates. Surgery. 2000;128:399–407.

    Article  PubMed  CAS  Google Scholar 

  43. Badimon JJ, Lettino M, Toschi V, Fuster V, Berrozpe M, Chesebro JH, et al. Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions. Circulation. 1999;99:1780–7.

    PubMed  CAS  Google Scholar 

  44. Westrick RJ, Bodary PF, Xu Z, Shen YC, Broze GJ, Eitzman DT. Deficiency of tissue factor pathway inhibitor promotes atherosclerosis and thrombosis in mice. Circulation. 2001;103:3044–6.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This investigation was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan, and from the Ministry of Health, Labor and Welfare of Japan.

Author information

Authors and Affiliations

  1. Department of Surgery, Kinki University School of Medicine, 377-2 Ohno-higashi, Osaka-sayama, 589-8511, Japan

    Takeo Yasuda, Takashi Ueda, Keiko Kamei, Wataru Shinzaki & Yoshifumi Takeyama

  2. Department of Surgery, Kobe University Graduate School of Medical Sciences, Kobe, 650-0017, Japan

    Hidehiro Sawa, Makoto Shinzeki & Yonson Ku

Authors
  1. Takeo Yasuda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takashi Ueda
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Keiko Kamei
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wataru Shinzaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hidehiro Sawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Makoto Shinzeki
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yonson Ku
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yoshifumi Takeyama
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Takeo Yasuda.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yasuda, T., Ueda, T., Kamei, K. et al. Plasma tissue factor pathway inhibitor levels in patients with acute pancreatitis. J Gastroenterol 44, 1071–1079 (2009). https://doi.org/10.1007/s00535-009-0096-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-009-0096-9

Keywords

Search

Navigation